Phase 2 Study of NU172 Anticoagulation in Patients Undergoing Coronary Artery Bypass Graft Surgery OFF-Pump.
Not yet recruiting
Phase of Trial: Phase II
Latest Information Update: 27 Feb 2017
At a glance
- Drugs NU 172 (Primary)
- Indications Thrombosis
- Focus Adverse reactions; Therapeutic Use
- Acronyms SNAP-CABG-OFF
- Sponsors ARCA biopharma Inc
- 09 Jun 2011 Planned end date changed from 1 Sep 2010 to 1 Sep 2013 as reported by ClinicalTrials.gov.
- 09 Jul 2009 Planned end date changed from Mar 2010 to Sep 2010 as reported by ClinicalTrials.gov.
- 19 Mar 2009 ARCA biopharma added as trial affiliate as reported by ClinicalTrials.gov.